Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 6—June 2020

Endemic Chromoblastomycosis Caused Predominantly by Fonsecaea nubica, Madagascar1

Tahinamandranto Rasamoelina, Danièle Maubon, Malalaniaina Andrianarison, Irina Ranaivo, Fandresena Sendrasoa, Njary Rakotozandrindrainy, Fetra A. Rakotomalala, Sébastien Bailly, Benja Rakotonirina, Abel Andriantsimahavandy, Fahafahantsoa Rakato Rabenja, Mala R. Andrianarivelo, Muriel CornetComments to Author , and Lala S. Ramarozatovo
Author affiliations: Université d’Antananarivo, Antananarivo, Madagascar (T. Rasamoelina, N. Rakotozandrindrainy, F.A. Rakotomalala, B. Rakotonirina, A. Andriantsimahavandy, M.Rakato Andrianarivelo); Université Grenoble Alpes, Grenoble, France (D. Maubon, S. Bailly, M. Cornet); Hôpital Universitaire Joseph Raseta Befelatanana, Antananarivo (M. Andrianarison, I. Ranaivo, F. Sendrasoa, F.R. Rabenja, L.S. Ramarozatovo); Centre Hospitalier Universitaire de Befelatanana, Antananarivo (L.S. Ramarozatovo)

Main Article

Table 3

Prevalence of chromoblastomycosis, Madagascar, March 2013–June 2017

Region No. persons* No. cases Prevalence
North and central north 3,629,908 20 0.55
Analanjirofo 1,151,536 2 0.17
Sava 1,091,102 16 1.47
Highlands 7,850,950 8 0.10
Analamanga 3,725,377 3 0.08
Amoron’i Mania 795,434 3 0.38
Itasy and Bongolava 1,324,044 0 0
West 1,870,459 1 0.05
Boeny and Menabe 1,548,299 0 0.00
East and South East 4,131,928 11 0.27
Alaotra Mangoro 1,142,612 4 0.35
Atsinanana 1,413,572 1 0.07
Vatovavy Fitovinany
South and South West 3,376,074 10 0.30
Androy 816,466 3 0.37
Anosy 747,352 6 0.80
Atsimo Andrefana 1,464,830 0 0
Ihorombe 347,427 1 0.29

*Determined at the end of the study period and calculated from the most recent figures available in 2013 and adjusted for subsequent years with a growth rate of 2.7%/year (World Bank estimates of demographic growth in Madagascar).
†No. cases/100,000 persons.

Main Article

1Preliminary results from this study were presented at the 20th International Society for Human and Animal Mycology Conference; June 29–July 5, 2018; Amsterdam, the Netherlands.

Page created: May 18, 2020
Page updated: May 18, 2020
Page reviewed: May 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.